The possible effects of sildenafil citrate administration at therapeutic dosage on visual acuity, color vision, intraocular pressure, macular thickness, macular volume, and central serous chorioretinopathy in patients with erectile dysfunction were evaluated.
The study consisted of 43 male patients diagnosed as having erectile dysfunction according to the first five question version of International Index of Erectile Function (IIEF-5). All patients were given sildenafil citrate 50 mg po 2 to 3 times/week for a month. The patients were evaluated at the first week and at the end of the treatment. The macular thickness and volume assessments with optic coherence tomography did not differ significantly in foveal, parafoveal areas, parafoveal superior hemisphere, parafoveal inferior hemisphere, parafoveal temporal, superior, nasal, and inferior quadrants. Central serous chorioretinopathy was not found in any of the patients.
Written by:
Damar E, Toklu Y, Tuncel A, Balci M, Aslan Y, Simsek S, Atan A. Are you the author?
Ministry of Health, Ankara Ataturk Research and Training Hospital, Department of Ophthalmology, Ankara, Turkey.
Reference: Am J Mens Health. 2013 Mar 10. Epub ahead of print.
doi: 10.1177/1557988313480808
PubMed Abstract
PMID: 23479433
UroToday.com Erectile Dysfunction Section
